Oppenheimer analysts hail TransMedics' recent quarter as 'bl...
Oppenheimer analysts hail TransMedics' recent quarter as 'blockbuster', emphasizing its long-term strategy to overcome short term challenges. The game-changing potential of the Organ Care System technology to reshape organ preservation and transport is also highlighted.
TransMedics' Stock Pops After Organ-transplant Company's 'Blockbuster' Third-quarter Results
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment